Searched for
NOVARTIS CONSUMER HEALTH
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- Jawed Zia quits Abbott IndiaJawed had joined the role in June 2018 after quitting Novartis within 15 days of being appointed to lead the Swiss drug company’s India bus...
- Novartis India appoints Milan Paleja as vice chairman and MDPaleja is currently country president at Novartis in India and is also responsible for the pharmaceuticals business in the country. He is a...
- Taro appoints Mariano Balaguer its new CFOTaro said Balaguer comes with 20 years of experience in finance with global companies such a Novartis Consumer Health, Nestle and Henry Sch...
- Sanofi, Boehringer Ingelheim seek CCI nod for $25-billion global asset swap dealThe commission will review if the two companies swapping their businesses will cause any adverse impact on the local competition.
- Novartis India Q2 net rises over 600% to Rs 104 croreIn April, Novartis had agreed to divest its global Animal Health business to Lilly by transferring it to Elanco India or another affiliate ...
- Doubts grow over GlaxoSmithKline's $6 bln capital return planwith the drugmaker's dividend under pressure following several years of stagnant growth, some believe it might make more sense to cancel th...
- Novartis Q3 net loss at Rs 1.18 croreThe company had posted a net profit of Rs 15.23 crore in the same period last fiscal, Novartis India said in a filing to the Bombay Stock E...
- Competition Commission of India clears Novartis-GlaxoSmithKline pharma dealThe multi-layered deal involves UK-based GlaxoSmithKline acquiring Novartis's vaccine biz, while latter would purchase GSK's cancer drugs p...
- Dr Reddy's acquires Habitrol brandDr Reddy's Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from Novartis Consumer Health Inc.
- Novartis India Q1 net profit up 3% at Rs 14.31 croreThe company had posted a net profit of Rs 13.87 crore for the corresponding period of the previous fiscal.
- Novartis India rallies over 2% on three way deal with GlaxoSmithKlineGSK will sell its portfolio of cancer drugs to Novartis for $14.5 billion, plus another $1.5 billion, depending on trials in progress, ET r...
- Novartis buys GSK's cancer drugs for $14.5 billion in a 3-way dealThe collaboration between the two will create a new world-leading consumer healthcare business with $10 billion in annual sales.
- Novartis revamps pharma world with mega-deals with GSK, Eli LillyThe Swiss drugmaker said it would divest its vaccines business, excluding flu, to GSK for $7.1 million plus royalties.
- Novartis India surges 20% as parent company strikes $15 billion deal with GSK, LillyNovartis on Tuesday said it will buy GSK's oncology products business. Separately, Novartis said it will sell off its animal health divisio...
- Novartis, GlaxoSmithKline, Pfizer & Ranbaxy focus on hinterlandBig drugmakers such as Novartis, GlaxoSmithKline, Pfizer, Ranbaxy and Aventis are keen to emulate the consumer industry's success in the hi...
- Novartis to fully integrate Alcon by end-2010Swiss drug maker, Novartis, is looking at fully integrating US-based eye-care group Alcon from Nestle by the end of this year, a top compan...
- 'There's room for low-priced generics’Novartis has recognised the growth potential of rural India early on. ET caught up with Olivier Jarry, senior vice president (strategy and ...
- Novartis posts 7% rise in Q1 net profitPharmaceuticals maker Novartis AG reported a 7 percent rise in first-quarter net income on Monday on the back of a declining dollar and sol...
- Novartis buys stake in Nestle eyecare unit for $11 bnNestle based in Switzerland said it would use the funds from the divestment to support opportunities for growth. Go nutty for health | In P...
Load More
